MedicinePopulation Health SciencesPreventive MedicineEpidemiologyGenetic CounselingReproductive EpidemiologyCystic FibrosisMutation ScreeningPopulation ScreeningReproductive Health SurveillanceScreeningTargeted ScreeningCarrier ScreeningCystic Fibrosis GeneticsCystic Fibrosis ScreeningFamily History-based Screening
We used signs and letters to offer free cystic fibrosis (CF) carrier screening to nonpregnant adults in stable relationships who visited numerous clinical and nonclinical sites in Nashville. A total of 179 individuals (<<1% of those eligible) elected to be tested. To understand this observation, we used questionnaires to assess individuals' attitudes about genetic testing in general and about CF carrier screening in particular (n=873). Participants expressed conflicting views about carrier screening. More than 90% of people thought that genetic testing should at least be available. Most respondents said that the views of their partners and physicians were important in their decision making, and most believed that these others favored genetic testing. Yet, more than two-thirds indicated that such factors as insurability, being "at risk," what they would need to learn, abortion, and religious beliefs were important in their decision making, opinions that mitigated against genetic testing. In particular, one-third feared that carriers would lose their health insurance, one-quarter said that they would have been more interested had they been able to provide DNA by buccal swab rather than by finger stick, and less than one-sixth believed that genetic testing was meddling in God's plan. In the face of both the low level of use of free CF carrier screening by nonpregnant couples when it was not offered in person by health-care professionals and the wide variety of concerns demonstrated, we believe that clinicians should not routinely offer carrier screening to nonpregnant individuals who do not have a family history of CF.
16
Discrimination as a consequence of genetic testing.
Paul R. Billings, Melvin A. Kohn, Margaret de Cuevas et al. · PubMed · 1992 · 487 citations
Life Sciences, Genetics, Psychology +11
Tay-Sachs Disease— Carrier Screening, Prenatal Diagnosis, and the Molecular Era
Michael M. Kaback · JAMA · 1993 · 257 citations
Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
Hilary Bekker, Michael Modell, G Denniss et al. · BMJ · 1993 · 199 citations · Full text